- Q1 2024 Incyte Corp Earnings Call TranscriptApr 30, 2024$52.05 (-0.97%)Earnings
- Q4 2023 Incyte Corp Earnings Call TranscriptFeb 13, 2024$59.34 (+2.59%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Incyte Corp at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Incyte Corp to Discuss the Key Data Presentations at ASH TranscriptDec 11, 2023
- Incyte Corp at Evercore ISI HealthCONx Conference TranscriptNov 30, 2023
- Incyte Corp at Guggenheim Securities Inflammation & Immunology Conference TranscriptNov 07, 2023
- Q3 2023 Incyte Corp Earnings Call TranscriptOct 31, 2023$53.93 (+3.39%)Earnings
- Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- Incyte Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Incyte Corp at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Incyte Corp Earnings Call TranscriptAug 01, 2023$63.69 (-0.05%)Earnings
- Incyte Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Incyte Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Incyte Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Incyte Corp at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Incyte Corp Earnings Call TranscriptMay 02, 2023$69.96 (-7.14%)Earnings
- Incyte Corp at Cowen Health Care Conference TranscriptMar 06, 2023
- Incyte Corp at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 08, 2023
- Q4 2022 Incyte Corp Earnings Call TranscriptFeb 07, 2023$80.96 (-4.03%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Incyte Corp at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Incyte Corp Analyst and Investor Event TranscriptDec 12, 2022
- Incyte Corp at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Incyte Corp at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Incyte Corp Earnings Call TranscriptNov 01, 2022$76.95 (+3.51%)Earnings
- Incyte Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Incyte Corp Earnings Call TranscriptAug 02, 2022$72.58 (-6.23%)Earnings
- Incyte Corp to Discuss Opzelura In Vitiligo FDA Approval Call TranscriptJul 19, 2022
- Incyte Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Incyte Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Incyte Corp Earnings Call TranscriptMay 03, 2022$77.18 (+1.49%)Earnings
- Incyte Corp at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Incyte Corp at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Incyte Corp Earnings Call TranscriptFeb 08, 2022$70.07 (-4.47%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Incyte Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Incyte Corp at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Incyte Corp to Discuss Highlights from Oral PD-L1 Program from SITC TranscriptNov 13, 2021
- Incyte Corp at BMO Capital Markets Biopharma Spotlight Series: Oncology (Virtual) TranscriptNov 08, 2021
- Q3 2021 Incyte Corp Earnings Call TranscriptNov 02, 2021$63.48 (-8.46%)Earnings
- Incyte Corp GVHD Update Call: Approval in cGVHD and Syndax Collaboration TranscriptSep 27, 2021
- Syndax Pharmaceuticals Inc and Incyte Corp Axatilimab Collaboration Call TranscriptSep 27, 2021
- Incyte Corp to Discuss Opzelura (ruxolitinib) Cream FDA Approval Call TranscriptSep 22, 2021
- Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Incyte Corp Earnings Call TranscriptAug 03, 2021$77.95 (-0.66%)Earnings
- Incyte Corp at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 28, 2021
- Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Incyte Corp Sustainability Roundtable's CEO Investor Forum TranscriptJun 07, 2021
- Incyte Corp at William Blair Growth Stock Conference (Virtual) TranscriptJun 03, 2021
- Incyte Corp at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Incyte Corp Earnings Call TranscriptMay 04, 2021$81.03 (-5.25%)Earnings
- Incyte Corp Data Highlights on Adenosine Program from AACR 2021 TranscriptApr 12, 2021
- Incyte Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Incyte Corp Earnings Call TranscriptFeb 09, 2021$89.46 (-4.44%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Incyte Corp Data Highlights from ASH 2020 TranscriptDec 07, 2020
- Incyte Corp at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Q3 2020 Incyte Corp Earnings Call TranscriptNov 05, 2020$84.65 (-7.19%)Earnings
- MorphoSys AG and Incyte Corp to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas Investor Call TranscriptSep 29, 2020
- Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Incyte Corp Earnings Call TranscriptAug 04, 2020$99.95 (-1.81%)Earnings
- Incyte Corp at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) TranscriptJun 23, 2020
- Incyte Corp at JMP Securities Life Sciences Conference TranscriptJun 18, 2020
- Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Incyte Corp at RBC Global Healthcare Conference TranscriptMay 19, 2020
- Q1 2020 Incyte Corp Earnings Call TranscriptMay 05, 2020$98.82 (-2.15%)Earnings
- Incyte Corporation - Pemazyre FDA Approval TranscriptApr 20, 2020
- Incyte Corp Corporate Call - Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis TranscriptApr 06, 2020
- Incyte Corp at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Incyte Corp Earnings Call TranscriptFeb 13, 2020$78.05 (+2.93%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- MorphoSys AG and Incyte Sign Global Collaboration and License Agreement for Tafasitamab Conference Call TranscriptJan 13, 2020
- Incyte Corp GRAVITAS-301 Call TranscriptJan 02, 2020
- Incyte Corp at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- Incyte Corp at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Incyte Corp Earnings Call TranscriptOct 29, 2019$83.35 (+4.37%)Earnings
- Incyte Corp Call to Discuss Pemigatinib Development Update from European Society for Medical Oncology TranscriptSep 27, 2019
- Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 18, 2019
- Incyte Corp at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Incyte Corp Earnings Call TranscriptJul 30, 2019$85.43 (+6.44%)Earnings
- Zai Lab Ltd and Incyte Corp to Discuss the Collaboration and License Agreement for INCMGA0012 in Greater China Call TranscriptJul 02, 2019
- Incyte Corp Key Studies Within Its Inflammation And Autoimmunity portfolio Corporate Call TranscriptJun 17, 2019
- Incyte Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Incyte Corp at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- Incyte Corp at UBS Global Healthcare Conference TranscriptMay 20, 2019
- Incyte Corp at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Incyte Corp Earnings Call TranscriptApr 30, 2019$76.8 (+3.25%)Earnings
- Incyte Corp at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Incyte Corp at Cowen and Company Health Care Conference TranscriptMar 11, 2019
- Q4 2018 Incyte Corp Earnings Call TranscriptFeb 14, 2019$83.42 (+2.91%)Earnings
Zai Lab Ltd and Incyte Corp to Discuss the Collaboration and License Agreement for INCMGA0012 in Greater China Call Transcript
Hello, ladies and gentlemen, thank you for standing by and welcome to Zai Lab's Conference Call to discuss its development and exclusive commercial collaboration and license agreement with Incyte. (Operator Instructions).
As a reminder, today's call is being recorded. It is now my pleasure to turn the call over to Billy Cho, Chief Financial Officer of Zai Lab, who will make introductory comments. Please go ahead, sir.
Thank you, operator. Good morning, everyone, and welcome to Zai Lab's Conference Call to discuss our development and exclusive commercial collaboration and license agreement for INCMGA0012, an investigational anti-PD-1 monoclonal antibody with Incyte. Earlier today, Zai Lab and Incyte issued a release providing the details of agreement. The press release is available in the IR section of the company's corporate website at ir.zailaboratory.com.
Joining me on this call will be Dr. Samantha Du, Zai Lab's Chairman and Chief Executive Officer; Tao Fu, President and COO; Jonathan Wang, Head of BD
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)